MINT-QUETIAPINE XR
MINT PHARMACEUTICALS INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MINT-QUETIAPINE XR in Canada?
Yes. MINT-QUETIAPINE XR 400MG has an active shortage reported to Health Canada (last updated September 25, 2026).
Why is MINT-QUETIAPINE XR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MINT-QUETIAPINE XR be available again?
The estimated resolution date (January 30, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
QUETIAPINE XR
Extended-ReleasePRO DOC LIMITEE
Other Products
SEROQUEL
CHEPLAPHARM ARZNEIMITTEL GMBH
ACCEL-QUETIAPINE
ACCEL PHARMA INC
DOM-QUETIAPINE
DOMINION PHARMACAL
IPG-QUETIAPINE
MARCAN PHARMACEUTICALS INC
QUETIAPINE
SIVEM PHARMACEUTICALS ULC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-01-30
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02522225
Strength
400MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Active Ingredient
QUETIAPINE
Tier
Unrated
Last Updated
2026-09-25
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
10MG · DIN 02468840
25MG · DIN 02468859
800MG · DIN 02524724
400MG · DIN 02524716
200MG · DIN 02524708
70.0MG · DIN 02394871
10MG · DIN 02362678
5MG · DIN 02362651
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430